The Weekly Litigation News Digest is now live. Subscribe now

Ionis Pharmaceuticals competitive analysis

Loading summary...

Explore patent oppositions filed by Ionis Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Nov 13, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antisense DesignROCHENov 12, 2020

Explore Ionis Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
Jul 17, 2024Modulation Of Ube3A-Ats Expression3
Aug 23, 2023Modulation Of Apolipoprotein C-Iii (Apociii) Expression In Lipoprotein Lipase Deficient (Lpld) Populations1
Dec 14, 2022Methods For Modulating C9Orf72 Expression2
Jul 1, 2020Modulation Of Ube3A-Ats Expression1
Jun 10, 2020Linkage Modified Gapped Oligomeric Compounds And Uses Thereof1
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
Aug 21, 2019Modulation Of Dystrophia Myotonica-Protein Kinase (Dmpk) Expression1
Aug 14, 2019Selective Reduction Of Allelic Variants1
Mar 27, 2019Selective Reduction Of Allelic Variants1
Dec 26, 2018Modulation Of Alpha Synuclein Expression1

Latest PTAB cases involving Ionis Pharmaceuticals

Discover the latest PTAB cases involving Ionis Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ionis Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
IONIS PHARMACEUTICALS117 - -
HOFFMANN EITLE148 - - -
ROCHE372534
STRAWMAN339 - - -